This presentation of Cancer Transitions will be conducted in Spanish, and will runs from April 14 until May 19. Each weekly session lasts for 2 - 2 1/2 hours and includes information on nutrition, exercise, coping with stress, and medical care, plus delicious healthy snacks. This program is open to cancer patients who have completed treatment and their loved ones.
Androgen Recepotr Activity Abnormality in Castration-Resistant Prostate Cancer Defined by Functional Enhancer RNAs
Haojie Huang, PhD, Professor, Department of Biochemistry/Molecular Biology and Urology, Mayo Clinic College of Medicine
Join the UNC Cancer Network for an online telehealth lecture with Melissa Troester, PhD. Participants will learn about the subtypes of breast cancer and how they are identified with tissue biomarkers, differences in risk factor and survivorship profiles for breast cancer subtypes, and racial disparities in incidence and mortality from breast cancer and the research challenges for understanding and resolving disparities.
Professor Frances Balkwill, Professor of Cancer Biology, Centre for Cancer and Inflammation, Barts Cancer Institute, John Vane Science Centre
Part of the Pharmacology Seminar Series. Andrea Ventura, MD, PhD, Associate Member, Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center.
Lydia Bourouiba, Ph.D., Massachusetts Institute of Technology
With over 6,400 runners in 2015, the Tar Heel 10 Miler is designed to celebrate YOU and showcase downtown Chapel Hill, the UNC campus and the surrounding historic neighborhoods. A true Carolina showcase with thousands of UNC alumni crossing the finish line each year. The Tar Heel 10 Miler benefits the UNC Lineberger Comprehensive Cancer Center and the Chapel Hill-Carrboro YMCA’s We Build People Campaign.
This presentation of Cancer Transitions will be conducted in Spanish, and will run from April 14 until May 19. Each weekly session lasts for 2 - 2 1/2 hours and includes information on nutrition, exercise, coping with stress, and medical care, plus delicious healthy snacks. This program is open to cancer patients who have completed treatment and their loved ones.
Interferon Regulatory Factor-1: a brake to limit gammaherpesvirus chronic infection and lyphomagenesis
Vera Tarakanova, PhD, Microbiology and Molecular Genetics, Cancer Center, Medical College of Wisconsin
Bill Schief, PhD, Scripps